The candidate in question is VY9323, an AAV gene therapy combining a highly potent pri-miRNA against superoxide dismutase 1 ...
Living in a disadvantaged community may decrease the length of time a person can survive with amyotrophic lateral sclerosis, or ALS, by over 30%, a study suggests. Similar studies have shown that ...
Living in a disadvantaged community may decrease the length of time a person can survive with amyotrophic lateral sclerosis, or ALS, by over 30%, a Michigan Medicine-led study suggests.
A trial that will test a noninvasive device called MyoRegulator as a treatment for ALS was cleared to start enrolling ...
Ncardia’s iPSC-derived microglia may aid ALS research and help to screen new therapies that target inflammation in ALS.
Hawking authored numerous books throughout his career and gave guest lectures around the world despite being paralyzed from amyotrophic lateral sclerosis, commonly known as ALS or Lou Gehrig’s ...